Strategic Investment, March 2023 Issue
Strategic Investment 2023 Economic Outlook
Creating a Cell and Gene Platform to Reprogram Patient T-Cells to Attack and Destroy Solid Tumor Cancer Cells
The financial upside for investors in developing a therapy that teaches the human immune system to kill solid tumor cancer cells using CAR-T Cell Therapy amounts to $1.96 Billion market annually
(February 8, 2023)
More Special Reports
Take Profits of over $922
Close 200 shares of ProShares UltraShort Bloomberg. Crude Oil NYSEArca: SCO
(#060: March 15, 2023)
By 2025, the Global Cannabis Industry is Expected to Reach $56 Billion
This incredible medical cannabis startup promises to assist those with Post-Traumatic Stress Disorder by researching, developing, and producing targeted cannabinoid health products for General Depression, Anxiety and PTSD.
(#013: September 15, 2022)
Use our contact form to send feedback; choose
"Editor" in the pulldown menu. Your feedback and the editor's response may be posted here.